Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE-therapeutics Share News (ETX)

Share Price Information for E-therapeutics (ETX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9.50
Bid: 9.30
Ask: 9.50
Change: -0.35 (-3.59%)
Spread: 0.20 (2.151%)
Open: 9.55
High: 10.00
Low: 9.50
Prev. Close: 9.75
ETX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EXECUTIVE CHANGES: New CFOs for Sensyne, Focusrite, Bango, 4D Pharma

Mon, 01st Mar 2021 16:41

(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:

----------

Sensyne Health PLC - Oxford, England-based clinical technology using artificial intelligence - Moves Chief Investment Officer Richard Pye to chief financial officer and executive director, while interim CFO Michael Norris moves to non-executive director, both from last Friday. Norris has been interim CFO since March last year. Additionally, Geoff Race joins the board as non-executive director. Race is co-founder and CFO of Nasdaq-listed biopharmaceutical company Minerva Neurosciences Inc.

----------

Focusrite PLC - High Wycombe, Buckinghamshire-based music and audio products - Sally McKone joins board and takes over as CFO on Monday, replacing Jeremy Wilson. McKone's appointment was announced back in September. McKone was divisional finance and IT director for Precision Engineering, the largest subsidiary of IMI PLC.

----------

Bango PLC - Cambridge, England-based e-commerce platform - Hires Matt Garner as CFO and board member, effective immediately. Garner joins from satellite communications technology firm Global Invacom Group Ltd. Garners departure from AIM-listed Global Invacom was announced back in December. The Singapore-based company, which reported 2020 results on Monday, says it has no current intention to appoint a new CFO, with its two financial controllers running finance instead. Bango says Garner replaces Carolyn Rand, who steps down as CFO and from the board but will remain as a consultant for the coming year. Rand was hired as interim CFO in October 2018 and became full-time CFO in January 2019. Bango will publish its 2020 results on March 16.

----------

4D Pharma PLC - Leeds-based live biotherapeutic products developer - Appoints John Beck, most recently chief financial officer at Ritter Pharmaceuticals Inc, as its own CFO. Beck oversaw Ritter's merger with Qualigen Therapeutics Inc, completed in May last year. Also hires Paul Maier as non-executive director. Maier was CFO of Sequenom Inc and of Nasdaq-listed Ligand Pharmaceuticals Inc.

----------

TBC Bank Group PLC - financial services in Georgia and Uzbekistan - Nikoloz Enukidze steps down as chair of board of TBC Bank Group PLC and of the supervisory board of TBC Bank JSC, effective immediately. Senior Independent Director Arne Berggren will take over both chairs, and Tsira Kemularia is promoted to interim senior independent director. Enukidze will remain for now a member of both boards but won't seek re-election at the 2021 annual general meeting. Nicholas Haag and Eric Rajendra also will step down as non-executive directors at the AGM.

----------

Herald Investment Trust PLC - invests for capital gains from smaller technology, communications and multi-media stocks - Chair Ian Russell resigns from board effective immediately "for personal reasons". Senior Independent Director Tom Black, on the board since 2013, succeeds Russell as chair.

----------

e-Therapeutics PLC - Oxford, England-based drug discovery using computers - Splits role of executive chair and chief executive, effective immediately. Independent Non-Executive Director Trevor Jones becomes non-executive chair, while Ali Mortazavi continues as CEO. Seeking additional non-executive director for board.

----------

Informa PLC - London-based business media, training and events - Senior Independent Director Gareth Bullock to step down from board at June AGM, having served for seven years. Meanwhile, Chief Operating Officer Patrick Martell joins the board on Monday as an executive director. Martell also is a non-executive director of education technology firm RM PLC.

----------

MJ Gleeson PLC - Sheffield-based housebuilder - Hires Elaine Bailey as non-executive director starting Monday. Until 2019, Bailey was chief executive of Hyde Housing Group, a London-based housing association with 50,000 properties. Bailey also is a non-executive director of Residential Secure Income PLC.

----------

Just Group PLC - Surrey, England-based retirement income products provider - Hires Kalpana Shah as non-executive director, starting Monday. Kalpana is a 30-year veteran of the insurance and investment industry, Just Group says. She was chief actuary and a partner at Hiscox Ltd until 2016.

----------

Ferrexpo PLC - Baar, Switzerland-based iron-ore miner in Ukraine - Hires Ann-Christin Andersen as independent non-executive director. Anderson was chief digital officer of energy technology and services firm TechnipFMC and managing director of TechnipFMC Norway. Anderson also is a non-executive director of flow control and instrumentation firm Rotork PLC.

----------

AdEPT Technology Group PLC - information technology provider based in London - Says by mutual consent will not re-appoint Christopher Kingsman as non-executive director. Back in February, AdEPT had said Kingsman would rejoin the board starting March 1.

----------

First Derivatives PLC - Newry, Northern Ireland-based consulting and software for finance, automotive and energy industries - Hires Scott Matthews as CEO for predictive intelligence business MRP. Matthews joins from Crowdtwist, a customer loyalty solutions provider that was acquired by Oracle Corp. He replaces MRP Co-Founder Kevin Cunningham, who steps down after 13 years as CEO. First Derivatives also hires Eric Raab to be chief technology officer of analytics software business KX. Raab joins on Monday from Information Builders Inc, a data and analytics software company where he also was CTO. Both roles report to First Derivatives CEO Seamus Keating.

----------

Horizonte Minerals PLC - nickel mines in Brazil - Hires Michael Drake as head of Projects to oversee the development of Horizonte's two wholly owned projects, the Araguaia ferro-nickel project and the Vermelho nickel-cobalt project, both in Brazil. Drake will be based at Horzonte's Brazilian headquarters in Belo Horizonte. He is a mechanical engineer who previously worked at BHP Group PLC and Newcrest Mining Ltd.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 May 2014 10:51

e-Therapeutics Trading Up As Brain Cancer Trial To Resume Recruitment

LONDON (Alliance News) - Shares in e-Therapeutics PLC were trading higher Thursday after it said that it had been cleared by the US Food and Drug administration to resume recruiting patients for its Phase Ia study of compound ETS2101 in brain cancer. The company had previously paused recrui

Read more
7 Apr 2014 12:25

UPDATE: e-Therapeutics Appoints Steve Medlicott Chief Financial Officer

LONDON (Alliance News) - e-Therapeutics PLC Monday said that it had appointed Steve Medlicott as Chief Financial Officer, following the resignation of Daniel Elger with immediate effect, also announced Monday. Medlicott had advised the company on its GBP40 million fund-raising in 2013. Medl

Read more
7 Apr 2014 10:57

e-Therapeutics's Chief Financial Officer Daniel Elger Resigns

LONDON (Alliance News) - e-Therapeutics PLC Monday said that Daniel Elger has resigned as Chief Financial officer and a director of the company, with immediate effect. e-Therapeutics said that the company's finances will be managed on an interim basis by Paul Stockdale, who has been the com

Read more
31 Mar 2014 12:50

REPEAT: UK MIDDAY BRIEFING: Babcock JV Wins GBP7 Billion Nuclear Contract

LONDON (Alliance News) - Babcock International Group is leading the FTSE 100 higher Monday after its Cavendish Fluor Partnership joint venture was selected as the preferred bidder for a GBP7 billion nuclear plant decommissioning contract.

The joint venture with Fluo

Read more
31 Mar 2014 12:45

UK MIDDAY BRIEFING: Babcock JV Wins GBP7 Billion Nuclear Contract

LONDON (Alliance News) - Babcock International Group is leading the FTSE 100 higher Monday after its Cavendish Fluor Partnership joint venture was selected as the preferred bidder for a GBP7 billion nuclear plant decommissioning contract.

The joint venture with Flou

Read more
31 Mar 2014 10:35

UK WINNERS & LOSERS: Babcock Leads FTSE 100 Risers; Insurers Rebound

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Monday.

-------

FTSE 100 - WINNERS

Babcock International Group, up 3.5%. The company said its Cavendish Fluor Partnership has

Read more
31 Mar 2014 08:33

e-Therapeutics Rises As It Gets Good Interim Drug Trial Results

LONDON (Alliance News) - e-Therapeutics PLC Monday said it had achieved positive interim results from a UK study evaluating the safety, dosing and anti-tumour activity of its ETS2101 drug in patients with advanced solid cancer tumours. In a statement, the company said that it had completed

Read more
26 Mar 2014 13:40

UK MIDDAY BRIEFING: Government Completes 2nd Lloyds Bank Stake Sale

LONDON (Alliance News) - The UK government has raised a further GBP4.20 billion from its second sale of Lloyds Banking Group PLC shares, meaning it has now recouped GBP7.41 billion of the roughly GBP21 million that taxpayers injected into the bank during the financial crisis.<

Read more
26 Mar 2014 11:30

UK WINNERS & LOSERS: Standard Life Leads FTSE 100 Risers

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Wednesday.

-------

FTSE 100 - WINNERS

Standard Life, up 5.2%. The company has agreed to buy Ignis Asset Mana

Read more
26 Mar 2014 11:03

e-Therapeutics Gains As Recruitment For Cancer Trial Resumes

LONDON (Alliance News) - Shares in e-Therapeutics PLC jumped Wednesday morning after the biotechnology company said it has received approval from MHRA to recommence recruitment of new patients into its ETS2101 phase Ia solid tumours trial. Recruitment for the trial was temporarily paused ov

Read more
24 Jan 2014 12:41

UK MIDDAY BRIEFING: Bank Of England Now Focused On Productivity

LONDON (Alliance News) - Bank of England Governor Mark Carney Friday signaled that rising productivity will now be the key factor that decides when the central bank will start to tighten monetary policy, and any tightening will be a slow, gradual process.

In a speech at the World Ec

Read more
24 Jan 2014 11:01

e-Therapeutics Temporarily Halts Recruitment In Trial Due To Drug Supply Issue

LONDON (Alliance News) - Shares in e-Therapeutics PLC dropped 16% Friday morning after it said that it was temporarily halting recruitment into its ETS2101 cancer trials due to a drug supply issue. e-Therapeutics said that there had been a practical issue with the stored drugs for the trial

Read more
24 Jan 2014 10:58

UK WINNERS & LOSERS: Cairn Falls As Indian Tax Department Gets In Touch

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Friday. ------- FTSE 100 - WINNERS Weir Group, up 0.2%. The engineering company said it had won a USD98 million, or GBP59 million, two-year contract to provide

Read more
7 Jan 2014 08:22

AIM IN BRIEF: H&T Says Profit As Expected, But Gold Price Has Hurt

Read more
31 Oct 2013 13:36

e-Therapeutics Starts Phase IIb Trial Of Depressive Disorder Treatment

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.